Concerns and Advances Flashcards
Nosocomial Infections
hospital acquired infections. Are highly resistant to antimicrobials and disinfectants
Types of antimicrobial resistance
environmentally mediated resistance, microorganism mediated resistance
Environmentally mediated resistance
physical and chemical characteristics of the environment that alter the drug or physiologic response of the microorganism. Ex: pH
Types of Microorganism Mediated Resistance
Intrinsic Resistance, Acquired Resistance
Intrinsic Resistance
preexisting property. Ex: vancomycin resistance in gram negative pathogens, Aztreonam resistance in gram positive cocci
Acquired Resistance
resulting from altered cellular microbial physiology and structure due to genetic changes. Unpredictable event that can be acquired by mutation or horizontal gene transfer
Mechanisms of Antimicrobial Resistance
- prevention of penetration to target sites within microbe ex: outer membrane porin mutations
- Rapid efflux of antibiotics ex: tetracycline resistance
- enzymatic destruction or inactivation of drug. Ex: beta lactamases, aminoglycoside modifying enzymes
- Modification or protection of drugs target site. Ex: penicillin binding proteins, ribosome protection (tetracycline), mutations on DNA gyrase gene (fluoroquinolone)
Reasons for Emergence of Antimicrobial Resistance
- widespread antimicrobial use
- microbial adaptation and change
- changes in demographics
- medical advances (implants, catheters, biofilms)
- changes in ecosystems
- cutbacks in public health systems
Potential Impact of Antimicrobial Resistance
- increased mortality to infectious diseases
- veterinarian revisits
- high treatment costs
- productivity loss and economic impact
- zoonotic spread of resistant microbes
- increased nosocomial infection
Examples of problematic bacterial organisms
- enterococcus, enterobacter, pseuodomonas, acinetobacter: bacteria with high level resistance
- vancomycin resistant enterococcus
- methicillin resistant staphylococcus aureus (MRSA)
- extended spectrum beta lactamase (ESBL) producing E. coli and Klebsiella sp.
- fluoroquinolone resistant Campylobacter jejuni
- Multiple drug resistant (MDR) E. coli and Salmonells
- MDR and XDR mycobacterium tuberculosis
Imprudent use of antimicrobials by providers
over prescription for mild and non-bacterial infections. Over selection of broad-spectrum, costly, last-resort drugs
Imprudent use of antimicrobials by patients/clients
non-compliance, self-medication/OTC availability
Imprudent use of antimicrobials by industry
misleading promotions, competition between brands
Strategies to reduce antimicrobial resistance
- Prudent drug use
- Pathogen control
- Policy
Antimicrobial Stewardship
the actions taken to preserve the success and availability of antimicrobial drugs through careful oversight and responsible medical decision-making while protecting animal, public, and environmental health.